ID: ALA3650483

Max Phase: Preclinical

Molecular Formula: C36H36F2N8O5

Molecular Weight: 698.73

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(NCCOCCOCCNc1nc(Nc2ccc(C(=O)NCc3ccc(F)cc3)cc2)nc(Nc2ccc(O)c(F)c2)n1)c1ccccc1

Standard InChI:  InChI=1S/C36H36F2N8O5/c37-27-10-6-24(7-11-27)23-41-33(49)26-8-12-28(13-9-26)42-35-44-34(45-36(46-35)43-29-14-15-31(47)30(38)22-29)40-17-19-51-21-20-50-18-16-39-32(48)25-4-2-1-3-5-25/h1-15,22,47H,16-21,23H2,(H,39,48)(H,41,49)(H3,40,42,43,44,45,46)

Standard InChI Key:  MJEVARHXAVHJTA-UHFFFAOYSA-N

Associated Targets(non-human)

Slco2a1 Solute carrier organic anion transporter family member 2A1 (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 698.73Molecular Weight (Monoisotopic): 698.2777AlogP: 5.15#Rotatable Bonds: 18
Polar Surface Area: 171.65Molecular Species: NEUTRALHBA: 11HBD: 6
#RO5 Violations: 4HBA (Lipinski): 13HBD (Lipinski): 6#RO5 Violations (Lipinski): 4
CX Acidic pKa: 9.15CX Basic pKa: 5.96CX LogP: 5.81CX LogD: 5.78
Aromatic Rings: 5Heavy Atoms: 51QED Weighted: 0.05Np Likeness Score: -1.15

References

1.  (2015)  Prostaglandin transporter inhibitors and uses thereof, 

Source

Source(1):